|Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations|
KA Phillips, IM Collins, RL Milne, SA McLachlan, M Friedlander, M Hickey, ...
Human Reproduction 31 (5), 1126-1132, 2016
|Assessing and managing breast cancer risk: Clinicians' current practice and future needs|
IM Collins, E Steel, GB Mann, JD Emery, A Bickerstaffe, A Trainer, ...
The Breast 23 (5), 644-650, 2014
|Preventing breast and ovarian cancers in high-risk BRCA1 and BRCA2 mutation carriers|
IM Collins, RL Milne, PC Weideman, SA McLachlan, ML Friedlander, ...
Med J Aust 199 (10), 680-3, 2013
|Do BRCA1 and BRCA2 Mutation Carriers Have Earlier Natural Menopause Than Their Noncarrier Relatives? Results From the Kathleen Cuningham Foundation …|
IM Collins, RL Milne, SA McLachlan, M Friedlander, M Hickey, ...
Journal of clinical oncology 31 (31), 3920-3925, 2013
|iPrevent®: a tailored, web-based, decision support tool for breast cancer risk assessment and management|
IM Collins, A Bickerstaffe, T Ranaweera, S Maddumarachchi, L Keogh, ...
Breast cancer research and treatment 156, 171-182, 2016
|Women’s preferences for selective estrogen reuptake modulators: an investigation using the time trade-off technique|
AF Ralph, B Ager, ML Bell, IM Collins, L Andrews, K Tucker, N O’Reilly, ...
SpringerPlus 3 (1), 264, 2014
|Women's preferences for selective estrogen reuptake modulators: an investigation using protection motivation theory|
AF Ralph, B Ager, ML Bell, IM Collins, L Andrews, K Tucker, KA Phillips, ...
Patient education and counseling 96 (1), 106-112, 2014
|The tubal hypothesis of ovarian cancer: caution needed|
IM Collins, SM Domchek, DG Huntsman, G Mitchell
The lancet oncology 12 (12), 1089-1091, 2011
|Consumer and clinician perspectives on personalising breast cancer prevention information|
LA Keogh, E Steel, P Weideman, P Butow, IM Collins, JD Emery, ...
The Breast 43, 39-47, 2019
|Teletrials: implementation of a new paradigm for clinical trials|
IM Collins, K Burbury, CR Underhill
Medical Journal of Australia 213 (6), 263-265. e1, 2020
|Strategies for fertility preservation after chemotherapy awareness among Irish Cancer specialists|
IM Collins, MJ Kennedy
Irish Medical Journal, 2011
|A Discrete Choice Experiment to Examine the Preferences of Patients With Cancer and Their Willingness to Pay for Different Types of Health Care Appointments|
SF Wong, R Norman, TL Dunning, DM Ashley, M Khasraw, TM Hayes, ...
Journal of the National Comprehensive Cancer Network 14 (3), 311-319, 2016
|Carboplatin Dosing in Ovarian Cancer: Problems and Pitfalls|
IM Collins, R Roberts-Thomson, D Faulkner, D Rischin, M Friedlander, ...
International Journal of Gynecological Cancer 21 (7), 1213, 2011
|Clinical Decision Aids in Colon Cancer; A Comparison of Two Predictive Nomograms|
IM Collins, F Kelleher, C Stuart, M Collins, J Kennedy
Clinical Colorectal Cancer, 2011
|Transitioning to routine breast cancer risk assessment and management in primary care: what can we learn from cardiovascular disease?|
KA Phillips, EJ Steel, I Collins, J Emery, M Pirotta, GB Mann, P Butow, ...
Australian journal of primary health 22 (3), 255-261, 2016
|Implementation of the Australasian Teletrial Model: lessons from practice|
S Sabesan, J Zalcberg, C Underhill, R Zielinski, K Burbury, Z Ansari, ...
Asia Pac J Clin Oncol 15 (Suppl 8), 3-14, 2019
|Tailored NEOadjuvant epirubicin, cyclophosphamide and Nanoparticle Albumin-Bound paclitaxel for breast cancer: The phase II NEONAB trial—Clinical outcomes and molecular …|
C Murphy, A Muscat, D Ashley, V Mukaro, L West, Y Liao, D Chisanga, ...
PloS one 14 (2), e0210891, 2019
|The iPrevent online breast cancer risk assessment and risk management tool: Usability and acceptability testing|
LL Lo, IM Collins, M Bressel, P Butow, J Emery, L Keogh, P Weideman, ...
JMIR formative research 2 (2), e9935, 2018
|Influence of socioeconomic factors and distance to radiotherapy on breast‐conserving surgery rates for early breast cancer in regional Australia; implications of change|
IM Collins, C Lum, VL Versace
Asia‐Pacific Journal of Clinical Oncology 14 (5), e224-e230, 2018
|Electronic clinical decision support systems attitudes and barriers to use in the oncology setting.|
IM Collins, O Breathnach, P Felle
Irish Journal of Medical Science, 2012